Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
Contacts
Capabilities
Suggested News & Insights
DOJ’s Civil Rights Fraud Initiative Raises False Claims Act Risks for Healthcare and Life Sciences CompaniesJune 10, 2026President Trump Issues Executive Order to Enhance Customs EnforcementJune 9, 2026Prediction Markets and Insider Trading: Why Organizations Should Update Compliance Policies NowJune 8, 2026New Clarity Emerges on DOJ’s Fraud Enforcement ReorganizationJune 5, 2026Supreme Court Rules for SEC on Disgorgement AwardsJune 4, 2026DOJ Signals Increasing Scrutiny of Vertically Integrated Healthcare CompaniesJune 4, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory